Upload Avatar (500 x 500)
Ke Wei
Life Science
Tongji University
Shanghai
Language: English, Chinese
Cardiac Regeneration
Drug Screening
Cardiomyocyte Proliferation
Cardiomyocyte Maturation
Animal Models
Cardiac Injury
Stem Cells
Translational Medicine
Mirna
Small Molecule Inhibitors
Areas of Focus
- Cardiac development and regeneration
- High-content drug screening targeting cardiomyocyte proliferation and maturation
- Application of drugs in animal models of cardiac injury
Work Experience
- Current - Tongji University, School of Life Sciences and Technology - Professor
- Current - Affiliated Hospital of Oriental Medicine, Institute of Regenerative Medicine - Distinguished Researcher
Academic Background & Achievements
- Bachelor's Degree: Department of Biological Sciences and Technology, Tsinghua University
- PhD: Molecular, Cellular, and Integrative Physiology, University of California, Los Angeles
- Postdoctoral Research: Sanford Burnham Prebys Medical Discovery Institute
- Selected for the National Overseas High-Level Talents Youth Program
- Lead and participated in multiple national natural science projects and key research and development projects of the Ministry of Science and Technology
Publications
- Jmjd4 facilitates Pkm2 degradation in cardiomyocytes and is protective against dilated cardiomyopathy, Ke Wei*, Dachun Xu*, 2023
- Dynamic chromatin landscape encodes programs for perinatal transition of cardiomyocytes, Ke Wei*, Shaolin Shi*, Chaojun Li*, Jingping Yang*, 2023
- AP-1 activation mediates postnatal cardiomyocyte maturation, Ke Wei*, 2022
- Single-cell transcriptomics of cardiac progenitors reveals functional subpopulations and their cooperative crosstalk in cardiac repair, Ke Wei*, Hongming Zhu*, 2021
- Epicardial FSTL1 Reconstitution Regenerates the Adult Mammalian Heart, Ke Wei*, Pilar Ruiz-Lozano, 2015
